AstraZeneca Cancels Plans for £450 Million UK Vaccine Manufacturing Plant: A Blow to the Government’s Growth Agenda
AstraZeneca has decided to abandon plans for a £450 million vaccine manufacturing plant in the UK, following months of negotiations …